His areas of focus include the function of serotonin systems, drug discovery targeting serotonin systems to treat psychiatric disorders, the neurobiology of psychiatric disorders and pharmacology.Clint received his B.S in Psychology from the University of Florida and Doctorate in Neuroscience in 2006 from the University of Illinois, Urbana-Champaign. Clint is a member of the Society for Neuroscience and the American Society for Pharmacology and Experimental Therapeutics. Dr. Canal will be discussing the mechanisms of action of hallucinogenic drugs: from ketamine to lysergic acid diethylamide (LSD).LinksNortheasternAudioPsymposia Psychedelic NeuroscienceVideoPsymposia Psychedelic NeuroscienceWritingsThe serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen July 10, 2015/